Preventing pneumococcal infections in older adults

Lancet Respir Med. 2015 Nov;3(11):834-6. doi: 10.1016/S2213-2600(15)00365-3. Epub 2015 Oct 23.

Authors

Pekka Nuorti¹, Arthur Reingold²

Affiliations

¹ School of Health Sciences, Department of Epidemiology, University of Tampere, Tampere FI-33014, Finland; Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland. Electronic address: pekka.nuorti@uta.fi.
² School of Public Health, Division of Epidemiology, University of California, Berkeley, CA, USA.

PMID: 26607821
DOI: 10.1016/S2213-2600(15)00365-3

No abstract available

MeSH terms

Aged
Aged, 80 and over
Community-Acquired Infections / prevention & control
Cost-Benefit Analysis
Humans
Immunity, Herd
Middle Aged
Pneumococcal Vaccines / economics
Pneumococcal Vaccines / standards*
Pneumococcal Vaccines / therapeutic use
Pneumonia, Pneumococcal / prevention & control*
Vaccination / economics
Vaccination / standards*

Substances

13-valent pneumococcal vaccine
Pneumococcal Vaccines